Assenagon Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-341,463
| Closed | -$12.9M | – | 1443 |
|
|
2021
Q1 | $12.9M | Buy |
341,463
+114,238
| +50% | +$4.3M | 0.05% | 266 |
|
|
2020
Q4 | $3.87M | Sell |
227,225
-300,406
| -57% | -$5.11M | 0.02% | 372 |
|
|
2020
Q3 | $2.48M | Sell |
527,631
-122,369
| -19% | -$575K | 0.01% | 512 |
|
|
2020
Q2 | $3.97M | Buy |
650,000
+446,896
| +220% | +$2.73M | 0.03% | 362 |
|
|
2020
Q1 | $461K | Sell |
203,104
-73,027
| -26% | -$166K | ﹤0.01% | 617 |
|
|
2019
Q4 | $1.27M | Sell |
276,131
-211,726
| -43% | -$971K | 0.01% | 494 |
|
|
2019
Q3 | $1.89M | Buy |
487,857
+91,578
| +23% | +$355K | 0.01% | 376 |
|
|
2019
Q2 | $2.39M | Buy |
396,279
+241,579
| +156% | +$1.46M | 0.02% | 437 |
|
|
2019
Q1 | $2.07M | Buy |
+154,700
| New | +$2.07M | 0.02% | 471 |
|